PT835309E - Vacina contra agentes infecciosos composicao para o tratamento e a prevencao das infeccoes por hiv - Google Patents

Vacina contra agentes infecciosos composicao para o tratamento e a prevencao das infeccoes por hiv

Info

Publication number
PT835309E
PT835309E PT96924033T PT96924033T PT835309E PT 835309 E PT835309 E PT 835309E PT 96924033 T PT96924033 T PT 96924033T PT 96924033 T PT96924033 T PT 96924033T PT 835309 E PT835309 E PT 835309E
Authority
PT
Portugal
Prior art keywords
pct
hiv infections
prevention
treatment
infectious agents
Prior art date
Application number
PT96924033T
Other languages
English (en)
Inventor
Jean-Claude Chermann
Carole Le Contel
Pascale Galea
Original Assignee
Inst Nat S Et De La Rec Medi I
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Nat S Et De La Rec Medi I filed Critical Inst Nat S Et De La Rec Medi I
Publication of PT835309E publication Critical patent/PT835309E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PT96924033T 1995-06-30 1996-06-28 Vacina contra agentes infecciosos composicao para o tratamento e a prevencao das infeccoes por hiv PT835309E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9507914A FR2735984B1 (fr) 1995-06-30 1995-06-30 Vaccin contre des agents infectieux ayant une phase intracellulaire, composition pour le traitement et la prevention des infections a hiv, anticorps et procede de diagnostic

Publications (1)

Publication Number Publication Date
PT835309E true PT835309E (pt) 2002-03-28

Family

ID=9480577

Family Applications (1)

Application Number Title Priority Date Filing Date
PT96924033T PT835309E (pt) 1995-06-30 1996-06-28 Vacina contra agentes infecciosos composicao para o tratamento e a prevencao das infeccoes por hiv

Country Status (13)

Country Link
US (1) US6113902A (pt)
EP (1) EP0835309B1 (pt)
JP (1) JP4036895B2 (pt)
CN (1) CN1117148C (pt)
AT (1) ATE206456T1 (pt)
AU (1) AU6462396A (pt)
CA (1) CA2223825A1 (pt)
DE (1) DE69615685T2 (pt)
DK (1) DK0835309T3 (pt)
ES (1) ES2165510T3 (pt)
FR (1) FR2735984B1 (pt)
PT (1) PT835309E (pt)
WO (1) WO1997002344A2 (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2235420A1 (en) 1998-06-17 1999-12-17 Paolo Renzi Antisense oligonucleotides for treating or preventing atopic diseases and neoplastic cell proliferation
FR2836146B1 (fr) * 2002-02-15 2005-01-07 Urrma R & D IMMUNOGLOBULINE IgG3 MARQUEUR DE PROTECTION CONTRE LES MALADIES VIRALES INFECTIEUSES ET SES UTILISATIONS
EP1567545B1 (en) * 2002-12-06 2010-05-05 Zhi Cheng Xiao Peptides and their use in the treatment of central nervous system damage
TW200846363A (en) * 2007-03-22 2008-12-01 Urrma R & B Novel human anti-R7V antibodies and uses thereof
EP2374470A1 (fr) * 2010-04-08 2011-10-12 Beta Innov Utilisation thérapeutique de la protéine Beta2m
EP3512551A4 (en) * 2016-09-16 2020-08-05 The Brigham and Women's Hospital, Inc. BLOCUS OF INTERACTIONS OF ALPHAF TOPROTEIN (AFP) WITH MOLECULES ASSOCIATED WITH MICROGLOBULIN BETA2

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK160944C (da) * 1986-01-16 1991-10-21 Novo Industri As Modificerede beta2-mikroglobuliner og farmaceutiske praeparater indeholdende disse
US5733550A (en) * 1990-05-10 1998-03-31 Dana-Farber Cancer Institute, Inc. Method for enhancing the association of exogenous peptides with class I MHC molecules on the surface of antigen presenting cells with β-microglobulin
FR2675508A1 (fr) * 1991-04-18 1992-10-23 Tm Innovation Compose comprenant une sequence peptidique neutralisant l'infection par le cytomegalovirus humain (hcmv) et composition le comportant.
GB9201023D0 (en) * 1992-01-17 1992-03-11 Medical Res Council Vaccines
GB9214871D0 (en) * 1992-07-13 1992-08-26 Medical Res Council Vaccines
US6696061B1 (en) * 1992-08-11 2004-02-24 President And Fellows Of Harvard College Immunomodulatory peptides
GB9307371D0 (en) * 1993-04-08 1993-06-02 Walls Alan J Fusion proteins

Also Published As

Publication number Publication date
FR2735984A1 (fr) 1997-01-03
ATE206456T1 (de) 2001-10-15
CN1117148C (zh) 2003-08-06
DE69615685T2 (de) 2002-08-08
DE69615685D1 (de) 2001-11-08
AU6462396A (en) 1997-02-05
JP4036895B2 (ja) 2008-01-23
JPH11509407A (ja) 1999-08-24
EP0835309A2 (fr) 1998-04-15
FR2735984B1 (fr) 1997-09-19
ES2165510T3 (es) 2002-03-16
US6113902A (en) 2000-09-05
CN1193349A (zh) 1998-09-16
WO1997002344A3 (fr) 1997-03-06
EP0835309B1 (fr) 2001-10-04
CA2223825A1 (fr) 1997-01-23
DK0835309T3 (da) 2002-12-02
WO1997002344A2 (fr) 1997-01-23

Similar Documents

Publication Publication Date Title
PT1296711E (pt) E7 de vph para o tratamento do virus do papiloma humano
IL130931A0 (en) Small molecules useful in the treatment of inflammatory disease
DE69133516D1 (de) Behandlung von autoimmunkrankheiten durch orale verabreichung von autoantigenen
BG95935A (bg) Метод и средство за приемане на дексмедетомидин директно през кожата
LU91928I2 (fr) Ipilimumab et ses dérivés pharmaceutiquement acceptables (YERVOY®)
DE69332643D1 (de) Menschliche, neutralisierende, monoklonale antikörper gegen das respiratorische synzytialvirus
DK55891D0 (da) Matrix med immunomodulerende virkning
BR0107972A (pt) Uso de uma proteìna ou polinucleotìdeo tat do hiv, nef do hiv, ou tat do hiv ligado(a) a uma proteìna ou polinucleotìdeo nef do hiv (nef-tat), e de uma proteìna ou polinucleotìdeo gp120 do hiv, método para imunizar um ser humano contra o hiv, e, composição de vacina para o uso humano
HK1076379A1 (en) Use of a composition comprising anti-vla-1 antibody for the preparation of a pharmaceutical composition for the treatment of pulmonary fibrosis
DE69720056D1 (de) Chlamydia-impfstoffe und immunogene chlamydia-zusammensetzungen, die ein antigen der äusseren membran enthalten, sowie verfahren zu deren herstellung
ATE179614T1 (de) Herpes simplex virus vp16 impfstoffe
ES2173923T3 (es) Procedimiento que permite inactivar un virus en presencia de un polieter y de un agente.
PT835309E (pt) Vacina contra agentes infecciosos composicao para o tratamento e a prevencao das infeccoes por hiv
MX9101958A (es) Inhibidores de acat de urea de aminosulfonilo
NO962655D0 (no) Deutrerte virkestoffer i transdermal applikasjon
DK1237562T3 (da) Fremgangsmåde til fremstilling af mikania-ekstrakter, som indeholder mikanolid og dihydromikanolid, og anvendelse i behandlingen af prolifererende sygdomme
FR2735026B1 (fr) Composition capillaire comprenant un extrait de myrte, son procede de preparation et son utilisation notamment pour un traitement antipelliculaire.
GR3034155T3 (en) Water-soluble epipodophyllotoxin derivatives, preparation method therefor, and use thereof as a drug and for treating cancer
SE9400524D0 (sv) Energipreparat
DK0821593T3 (da) Konjugat af et aktivt middel, et protein og eventuelt et for kroppen ikke som fremmed anset nativt protein
BG102404A (en) The application of flupirtin for the prevention and treatment of diseases related to impairement of the haematopoeic cellular system
WO2000063386A3 (en) Prevention, diagnosis and treatment of lyme disease
UA32241A (uk) Спосіб лікування запалювальних процесів у експериментальних тварин
EP1419784A3 (en) Proteosome vaccines against toxins, allergy and cancer
UA37377A (uk) Спосіб отримання мазі для лікування захворювань, які викликані внутрішньоклітинними інфекційними агентами